Annual Shareholders Equity
$40.91 M
-$15.13 M-27.00%
December 31, 2023
Summary
- As of February 7, 2025, LTRN annual stockholders equity is $40.91 million, with the most recent change of -$15.13 million (-27.00%) on December 31, 2023.
- During the last 3 years, LTRN annual shareholders equity has risen by +$21.21 million (+107.67%).
- LTRN annual shareholders equity is now -42.84% below its all-time high of $71.57 million, reached on December 31, 2021.
Performance
LTRN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$26.60 M
-$4.33 M-14.01%
September 30, 2024
Summary
- As of February 7, 2025, LTRN quarterly stockholders equity is $26.60 million, with the most recent change of -$4.33 million (-14.01%) on September 30, 2024.
- Over the past year, LTRN quarterly shareholders equity has dropped by -$18.81 million (-41.43%).
- LTRN quarterly shareholders equity is now -67.46% below its all-time high of $81.73 million, reached on March 31, 2021.
Performance
LTRN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
LTRN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.0% | -41.4% |
| 3 y3 years | +107.7% | -64.9% |
| 5 y5 years | +10000.0% | - |
LTRN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.8% | at low | -62.8% | at low |
| 5 y | 5-year | -42.8% | +4236.7% | -67.5% | +4857.7% |
| alltime | all time | -42.8% | >+9999.0% | -67.5% | +4857.7% |
Lantern Pharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $26.60 M(-14.0%) |
| Jun 2024 | - | $30.93 M(-13.5%) |
| Mar 2024 | - | $35.77 M(-12.6%) |
| Dec 2023 | $40.91 M(-27.0%) | $40.91 M(-9.9%) |
| Sep 2023 | - | $45.41 M(-5.9%) |
| Jun 2023 | - | $48.26 M(-8.2%) |
| Mar 2023 | - | $52.58 M(-6.2%) |
| Dec 2022 | $56.04 M | $56.04 M(-5.1%) |
| Sep 2022 | - | $59.03 M(-3.4%) |
| Jun 2022 | - | $61.08 M(-6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $65.32 M(-8.7%) |
| Dec 2021 | $71.57 M(+263.3%) | $71.57 M(-5.5%) |
| Sep 2021 | - | $75.73 M(-4.9%) |
| Jun 2021 | - | $79.61 M(-2.6%) |
| Mar 2021 | - | $81.73 M(+314.9%) |
| Dec 2020 | $19.70 M(+1988.3%) | $19.70 M(-8.7%) |
| Sep 2020 | - | $21.57 M(-7.1%) |
| Jun 2020 | - | $23.23 M(+4229.5%) |
| Mar 2020 | - | $536.50 K(-43.1%) |
| Dec 2019 | $943.30 K(-567.4%) | $943.30 K |
| Dec 2018 | -$201.80 K | - |
FAQ
- What is Lantern Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for Lantern Pharma?
- What is Lantern Pharma annual shareholders equity year-on-year change?
- What is Lantern Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Lantern Pharma?
- What is Lantern Pharma quarterly shareholders equity year-on-year change?
What is Lantern Pharma annual stockholders equity?
The current annual shareholders equity of LTRN is $40.91 M
What is the all time high annual shareholders equity for Lantern Pharma?
Lantern Pharma all-time high annual stockholders equity is $71.57 M
What is Lantern Pharma annual shareholders equity year-on-year change?
Over the past year, LTRN annual stockholders equity has changed by -$15.13 M (-27.00%)
What is Lantern Pharma quarterly stockholders equity?
The current quarterly shareholders equity of LTRN is $26.60 M
What is the all time high quarterly shareholders equity for Lantern Pharma?
Lantern Pharma all-time high quarterly stockholders equity is $81.73 M
What is Lantern Pharma quarterly shareholders equity year-on-year change?
Over the past year, LTRN quarterly stockholders equity has changed by -$18.81 M (-41.43%)